Androgen receptor

Rb

Artikelnummer:AN011-H
Menge:
Technische Daten
Kontrolle:Prostate
Zelluläre Lokalisation:Nuclear
Vorbehandlung:ProTaqs® Antigen Enhancer I (Cat. No. 401602092)
Immunogen:Synthetic peptide of human Androgen Receptor protein N-terminal
Ig Unterklasse:IgG
Spezies:Rabbit
Status:In Vitro Diagnostic Use (IVD)
Change(s) made:Complete revision
Synonyme:AIS, AIS, ANDR_HUMAN, Androgen receptor (dihydrotestosterone receptor, testicular feminization, spinal and bulbar muscular atrophy, Kennedy disease), Androgen receptor, AR, DHTR, Dihydro Testosterone Receptor, Dihydrotestosterone receptor, HUMARA, HYSP1, HYSP1, KD, NR3C4, Nuclear receptor subfamily 3 group C member 4, SBMA, SMAX1, Spinal and bulbar muscular atrophy, TFM.
Verfügbar in folgenden Ländern:worldwide
Beschreibung

Androgen receptor (AR) belongs to the nuclear receptor family and is essential for hormone-refractory and hormone-sensitive prostate cancer. After activation by androgenic hormones testosterone or dihydrotestosterone in cytoplasm, AR translocates in the nucleus and promotes transcription of its target genes by binding to specific DNA sequences called AREs (androgen response elements). This activation mediates the development and maintenance of prostate. AR is expressed in epithelial and stromal cells in normal prostate. The detection of AR is helpful for the diagnosis of prostate cancer.

Literatur

[1] Guo Z, Dai B, Jiang T et al. (2006) Regulation of androgen receptor activity by tyrosine phosphorylation Cancer Cell 10(4):309-19.
[2] Callewaert L, Verrijdt G, Christiaens V et al. (2003) Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements. J Biol Chem 278(10):8212-8.
[3] Gao L and Alumkal J (2010) Epigenetic regulation of androgen receptor signaling in prostate cancer. Epigenetics 5(2):100-4.

Kontakt